EUVIMEDEUVIMED entdecken
Open Access

Microbial and Metabolite Signatures of Stress Reactivity in Ulcerative Colitis Patients in Clinical Remission Predict Clinical Flare Risk

Jonathan P Jacobs, Jenny S Sauk, Aaron I Ahdoot, Fengting Liang, William Katzka, Hyo Jin Ryu, Ariela Khandadash, Venu Lagishetty, Jennifer S Labus, Bruce D Naliboff, Emeran A Mayer

Inflammatory Bowel Diseases · 01.03.2024 · 30 (3) · 336-346

DOI: 10.1093/ibd/izad185 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inflammatory Bowel Diseases, online erschienen am 31.08.2023. Verfasst von Jonathan P Jacobs und 10 weiteren Autor:innen. Beteiligte Einrichtung: G. Oppenheimer Center for Neurobiology of Stress and Resilience, University of California Los Angeles, Los Angeles, CA, USA. Hauptthemen laut MEDLINE: Colitis, Ulcerative. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: CSRD VA, NIDDK NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Stress reactivity (SR) is associated with increased risk of flares in ulcerative colitis (UC) patients. Because both preclinical and clinical data support that stress can influence gut microbiome composition and function, we investigated whether microbiome profiles of SR exist in UC.

Methods

Ninety-one UC subjects in clinical and biochemical remission were classified into high and low SR groups by questionnaires. Baseline and longitudinal characterization of the intestinal microbiome was performed by 16S rRNA gene sequencing and fecal and plasma global untargeted metabolomics. Microbe, fecal metabolite, and plasma metabolite abundances were analyzed separately to create random forest classifiers for high SR and biomarker-derived SR scores.

Results

High SR reactivity was characterized by altered abundance of fecal microbes, primarily in the Ruminococcaceae and Lachnospiraceae families; fecal metabolites including reduced levels of monoacylglycerols (endocannabinoid-related) and bile acids; and plasma metabolites including increased 4-ethyl phenyl sulfate, 1-arachidonoylglycerol (endocannabinoid), and sphingomyelin. Classifiers generated from baseline microbe, fecal metabolite, and plasma metabolite abundance distinguished high vs low SR with area under the receiver operating characteristic curve of 0.81, 0.83, and 0.91, respectively. Stress reactivity scores derived from these classifiers were significantly associated with flare risk during 6 to 24 months of follow-up, with odds ratios of 3.8, 4.1, and 4.9. Clinical flare and intestinal inflammation did not alter fecal microbial abundances but attenuated fecal and plasma metabolite differences between high and low SR.

Conclusions

High SR in UC is characterized by microbial signatures that predict clinical flare risk, suggesting that the microbiome may contribute to stress-induced UC flares.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeHumansEndocannabinoidsRNA, Ribosomal, 16SBile Acids and SaltsEubacteriales

Stichwörter der Autor:innen

biomarkersflare predictionmetabolomicsmicrobiomestress reactivity

Substanzen

EndocannabinoidsRNA, Ribosomal, 16SBile Acids and Salts

Autor:innen und Institutionen

  • G. Oppenheimer Center for Neurobiology of Stress and Resilience, University of California Los Angeles, Los Angeles, CA, USA.
  • Vatche and Tamar Manoukian Division of Digestive Diseases, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
  • Goodman-Luskin Microbiome Center, University of California Los Angeles, Los Angeles, CA, USA.
  • Division of Gastroenterology, Hepatology and Parenteral Nutrition, Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, CA, USA.
  • A.T. Still University School of Osteopathic Medicine in Arizona, Mesa, AZ, USA.

Förderung

  • CSRD VA
  • NIDDK NIH HHS
  • NIH HHS
  • Crohn's and Colitis Foundation
  • National Institutes of Health

Zitieren

APA

Jacobs, J. P., Sauk, J. S., Ahdoot, A. I., Liang, F., Katzka, W., Ryu, H. J., Khandadash, A., Lagishetty, V., Labus, J. S., Naliboff, B. D., & Mayer, E. A. (2024). Microbial and Metabolite Signatures of Stress Reactivity in Ulcerative Colitis Patients in Clinical Remission Predict Clinical Flare Risk. Inflammatory Bowel Diseases, 30(3), 336-346. https://doi.org/10.1093/ibd/izad185

Vancouver

Jacobs JP, Sauk JS, Ahdoot AI, Liang F, Katzka W, Ryu HJ, et al. Microbial and Metabolite Signatures of Stress Reactivity in Ulcerative Colitis Patients in Clinical Remission Predict Clinical Flare Risk. Inflammatory Bowel Diseases. 2024;30(3):336-346. doi:10.1093/ibd/izad185

BibTeX
@article{Jacobs2024,
  author = {Jacobs, Jonathan P and Sauk, Jenny S and Ahdoot, Aaron I and Liang, Fengting and Katzka, William and Ryu, Hyo Jin and Khandadash, Ariela and Lagishetty, Venu and Labus, Jennifer S and Naliboff, Bruce D and Mayer, Emeran A},
  title = {Microbial and Metabolite Signatures of Stress Reactivity in Ulcerative Colitis Patients in Clinical Remission Predict Clinical Flare Risk},
  journal = {Inflammatory Bowel Diseases},
  year = {2024},
  volume = {30},
  number = {3},
  pages = {336--346},
  doi = {10.1093/ibd/izad185}
}
Kostenlos starten →